MercoPress, en Español

Montevideo, January 24th 2021 - 00:32 UTC

Tag: Instituto Butantan

  • Wednesday, January 13th 2021 - 09:20 UTC

    China's Sinovac vaccine is 50,38% effective according to leading Brazilian research center

    Instituto Butantan responsible for developing the vaccine and conducting trials in the country, announced last week the vaccine had a 78% overall efficacy

    Trials in Brazil show the Chinese COVID-19 vaccine Sinovac to be 50.38% effective, nearly 30 percentage points below the initial results released last week. The Instituto Butantan, the São Paulo-based research institute responsible for developing the vaccine and conducting trials in the country, announced last week the vaccine had a 78% overall efficacy, with total protection against severe cases.